Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EKNL getting some solid exposure:
OTC Stock Picks Newsletter Up 90% on Penny Stock EKO International
PR Web
http://www.equities.com/news/news-headline-story?dt=2012-10-26&val=637871&d=1&cat=headline
OTC Stock Picks is a premier penny stock newsletter focused on bringing investors the next great trading opportunity. The OTC Stock Picks team has been following EKO International (EKO) since $0.05, and alerted the company from the $0.40 range, and we are excited where EKO is headed in the near future!
EKO investors saw nearly 20% gains in the first 2 trading sessions this week. The Friday close for EKO shares was $0.62, and shares peaked at $0.76 this past Tuesday, giving the OTC Stock Picks team and subscribers a whopping 90% overall gain.
Shares rallied early this week after a Monday release from EKO announcing that MaloneBailey LLP, Certified Public Accounting Firm has been appointed as auditors of the Company. MaloneBailey is a market leader in the delivery of SEC audit services to small and mid-cap publicly traded clients, with over 100 U.S. listed public companies as clients, including NYSE, NASDAQ and AMEX listed companies.
This announcement comes on the heels of the October 15 release from EKO announcing that it has initiated the process of reducing the number of authorized common shares of the Company, from One Billion (1,000,000,000) to Seventy Five Million (75,000,000), and will initiate a share buy-back program upon reaching a positive income statement.
These combined releases glaringly suggest to the investment community that EKO management is committed to turning a profit at some point during the business cycle, and up-listing to a higher exchange, a feat that requires a $2.00 minimum per share price.
The ‘other’ main focus for investors of EKO International, of course, is product NC-Stat DPN, currently being utilized by doctors and patients in Wal-Mart Canada clinics and managed care organizations in the US, for assisting in detecting Diabetic Peripheral Neuropathies (DPN).
NC-Stat DPN is a MUCH needed product in a HUGE market! The annual cost of DPN has been estimated at $14 billion in the United States, where there are roughly 25 million diabetics.
Starting today, EKO’s joint venture partner on NC-Stat DPN, NeuroVasc Clinical Inc. (NCI), will be joining over 50 exhibitors at the Canadian Federation of Podiatric Medicine 13th Annual Conference in London, Ontario (October 26th and 27th, 2012) presenting FREMS (Frequency Rhythmic Electrical Modulation System) devices (used to treat DPN). Events such as this are custom-made for landing potential deals and contracts, as company leaders meet in person.
The OTC Stock Picks team wants to emphasize to investors, that EKO International is truly and up and coming company, with a much needed product in the marketplace, and is making all the right moves to attract investors.
As sales numbers and interest in NC-Stat DPN grow, and as share reduction and ‘march’ toward higher exchange status continues, the OTC Stock Picks team feels that a $2.00 per share price is a real possibility, leaving our 90% gains of Tuesday in the dust!
About OTC Stock Picks
The team is among the US market leaders in connecting penny stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the penny stock market.
The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter.
The company also offers investors Free Level II service and Free Real Time Stock Charts on its company website.
Disclaimer: OTC Stock Picks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell. Please visit http://www.otcstockpicks.net for a more complete list of risks and disclosures.
Read the full story at http://www.prweb.com/releases/EKNL/otcstockpicks/prweb10060165.htm
$EKNL getting some solid exposure:
OTC Stock Picks Newsletter Up 90% on Penny Stock EKO International
PR Web
http://www.equities.com/news/news-headline-story?dt=2012-10-26&val=637871&d=1&cat=headline
OTC Stock Picks is a premier penny stock newsletter focused on bringing investors the next great trading opportunity. The OTC Stock Picks team has been following EKO International (EKO) since $0.05, and alerted the company from the $0.40 range, and we are excited where EKO is headed in the near future!
EKO investors saw nearly 20% gains in the first 2 trading sessions this week. The Friday close for EKO shares was $0.62, and shares peaked at $0.76 this past Tuesday, giving the OTC Stock Picks team and subscribers a whopping 90% overall gain.
Shares rallied early this week after a Monday release from EKO announcing that MaloneBailey LLP, Certified Public Accounting Firm has been appointed as auditors of the Company. MaloneBailey is a market leader in the delivery of SEC audit services to small and mid-cap publicly traded clients, with over 100 U.S. listed public companies as clients, including NYSE, NASDAQ and AMEX listed companies.
This announcement comes on the heels of the October 15 release from EKO announcing that it has initiated the process of reducing the number of authorized common shares of the Company, from One Billion (1,000,000,000) to Seventy Five Million (75,000,000), and will initiate a share buy-back program upon reaching a positive income statement.
These combined releases glaringly suggest to the investment community that EKO management is committed to turning a profit at some point during the business cycle, and up-listing to a higher exchange, a feat that requires a $2.00 minimum per share price.
The ‘other’ main focus for investors of EKO International, of course, is product NC-Stat DPN, currently being utilized by doctors and patients in Wal-Mart Canada clinics and managed care organizations in the US, for assisting in detecting Diabetic Peripheral Neuropathies (DPN).
NC-Stat DPN is a MUCH needed product in a HUGE market! The annual cost of DPN has been estimated at $14 billion in the United States, where there are roughly 25 million diabetics.
Starting today, EKO’s joint venture partner on NC-Stat DPN, NeuroVasc Clinical Inc. (NCI), will be joining over 50 exhibitors at the Canadian Federation of Podiatric Medicine 13th Annual Conference in London, Ontario (October 26th and 27th, 2012) presenting FREMS (Frequency Rhythmic Electrical Modulation System) devices (used to treat DPN). Events such as this are custom-made for landing potential deals and contracts, as company leaders meet in person.
The OTC Stock Picks team wants to emphasize to investors, that EKO International is truly and up and coming company, with a much needed product in the marketplace, and is making all the right moves to attract investors.
As sales numbers and interest in NC-Stat DPN grow, and as share reduction and ‘march’ toward higher exchange status continues, the OTC Stock Picks team feels that a $2.00 per share price is a real possibility, leaving our 90% gains of Tuesday in the dust!
About OTC Stock Picks
The team is among the US market leaders in connecting penny stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the penny stock market.
The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter.
The company also offers investors Free Level II service and Free Real Time Stock Charts on its company website.
Disclaimer: OTC Stock Picks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell. Please visit http://www.otcstockpicks.net for a more complete list of risks and disclosures.
Read the full story at http://www.prweb.com/releases/EKNL/otcstockpicks/prweb10060165.htm
$EKNL Very nice read here todaybrian!! This is going to be huge!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=80959684
$EKNL Going to explode this week.. Shorts will be toast!!
$EKNL ~ All ABOARD/Extra Extra Read All About It!
The EKNL PR EXPRESS
|""""""""""""""""""""""I |"O" ~|""|\________|""|._._._.._.________|"|_________|""|_^
| EKNL..........EKNL........... I |--\--|----|."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/" []<
|_____________ | |===|==|====|=============|====================l>l>l>l>l>
"(@)(@)--(@)(@)"-"(@)(@)--------(@)(@)(@)(@)-----(@)(@)(@)(@)-------O-O
---------------------------------------------------------------------------------------------------------------------
http://ih.advfn.com/p.php?pid=news&symbol=EKNL
$EKNL ~ All ABOARD/Extra Extra Read All About It!
The EKNL PR EXPRESS
|""""""""""""""""""""""I |"O" ~|""|\________|""|._._._.._.________|"|_________|""|_^
| EKNL..........EKNL........... I |--\--|----|."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/"."/" []<
|_____________ | |===|==|====|=============|====================l>l>l>l>l>
"(@)(@)--(@)(@)"-"(@)(@)--------(@)(@)(@)(@)-----(@)(@)(@)(@)-------O-O
---------------------------------------------------------------------------------------------------------------------
http://ih.advfn.com/p.php?pid=news&symbol=EKNL
FDA approval for FREMS is huge for $EKNL.. Next week going to insane with everything coming together EKNL this wil be our "Perfect Storm"
$EKNL Is growing on the buzz cloud more awareness coming into this power house!!
http://investorshub.advfn.com/boards/tcloud2.aspx?i=12
$EKNL is definitely showing investors exactly how big this is getting and with recent monster updates unleashed and ready to be unleashed, investors can definitely see $2.00 per share near term.
EKNL shattered several ‘record’ closes last week and again today – We are in full blown BULLISH BREAKOUT MODE and will be the biggest winner of 2012 hands down!
EKNL also announced a reduction in authorized shares amount limit to 75 Million and will be buying back shares in the open market with proceeds received from their FREMS technology!
EKO International Corp. – Reduction of number of authorized common sharesPR Newswire(Mon 10:01AM EDT)
“Upon the achievement of a positive income statement and the repayment of its liabilities, the Company intends to initiate a program to buy-back common shares on the open market.”
This is insane, the only reason to buy back shares is of course to move prices up, but the underlying reason would be to get uplisted to the NASDAQ or NYSE board!
This was confirmed when the company announced they have initiated the process for uplisting and announces the selection of MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.
“The Company is in the process of retaining an in-house accountant and qualified auditors for the purpose of upgrading the Company’s tier on the OTC Markets as the next step toward providing investors with the “highest financial standards and superior information availability” – OTC Markets”
Even better, the company also confirmed sufficient cash flow to meet financial needs – that’s a HUGE step forward for the company
The Company believes that cash flow from sales this quarter will be sufficient to meet its current financial needs and will be sufficient to finance its marketing expansion.
This is exactly what we have seen with our other medical monster alert Life Advantage (LFVN) after filing their Audited statement were approved and uplisted to the NASDAQ board trading well over the $3 mark from just pennies.
$EKNL is definitely showing investors exactly how big this is getting and with recent monster updates unleashed and ready to be unleashed, investors can definitely see $2.00 per share near term.
EKNL shattered several ‘record’ closes last week and again today – We are in full blown BULLISH BREAKOUT MODE and will be the biggest winner of 2012 hands down!
EKNL also announced a reduction in authorized shares amount limit to 75 Million and will be buying back shares in the open market with proceeds received from their FREMS technology!
EKO International Corp. – Reduction of number of authorized common sharesPR Newswire(Mon 10:01AM EDT)
“Upon the achievement of a positive income statement and the repayment of its liabilities, the Company intends to initiate a program to buy-back common shares on the open market.”
This is insane, the only reason to buy back shares is of course to move prices up, but the underlying reason would be to get uplisted to the NASDAQ or NYSE board!
This was confirmed when the company announced they have initiated the process for uplisting and announces the selection of MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.
“The Company is in the process of retaining an in-house accountant and qualified auditors for the purpose of upgrading the Company’s tier on the OTC Markets as the next step toward providing investors with the “highest financial standards and superior information availability” – OTC Markets”
Even better, the company also confirmed sufficient cash flow to meet financial needs – that’s a HUGE step forward for the company
The Company believes that cash flow from sales this quarter will be sufficient to meet its current financial needs and will be sufficient to finance its marketing expansion.
This is exactly what we have seen with our other medical monster alert Life Advantage (LFVN) after filing their Audited statement were approved and uplisted to the NASDAQ board trading well over the $3 mark from just pennies.
$EKNL is is MAJOR breakout action making another all-time high of $0.775 and is well on it’s way to soar towards $2 as MAJOR contract are unleashed next week.
Barchart.com maintains a “Strong” Buy opinion on EKNL and no doubt we will be breaking record after record next week when the sales contracts start flying out of the company.
http://www.barchart.com/opinions/stocks/EKNL
$EKNL is is MAJOR breakout action making another all-time high of $0.775 and is well on it’s way to soar towards $2 as MAJOR contract are unleashed next week.
Barchart.com maintains a “Strong” Buy opinion on EKNL and no doubt we will be breaking record after record next week when the sales contracts start flying out of the company.
http://www.barchart.com/opinions/stocks/EKNL
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference.. This is going to be "HUGE"
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference
$EKNL jumped to another record high price of $0.775 and with MAJOR contracts coming out of this weekend’s Medical Conference, expect EKNL to soar to more record highs.
EKNL is now at the 2012 CFPM 13th Annual Conference and we are getting initial word that key participants are very interested in EKNL and it’s FREMS technology.
The company announced already they are looking to finalized several deals, and we will be front and center when EKNL unleashes contract after contract.
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
$EKNL is is MAJOR breakout action making another all-time high of $0.775 and is well on it’s way to soar towards $2 as MAJOR contract are unleashed next week.
Barchart.com maintains a “Strong” Buy opinion on EKNL and no doubt we will be breaking record after record next week when the sales contracts start flying out of the company.
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference
EKNL jumped to another record high price of $0.775 and with MAJOR contracts coming out of this weekend’s Medical Conference, expect EKNL to soar to more record highs.
EKNL is now at the 2012 CFPM 13th Annual Conference and we are getting initial word that key participants are very interested in EKNL and it’s FREMS technology.
The company announced already they are looking to finalized several deals, and we will be front and center when EKNL unleashes contract after contract.
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference
EKNL jumped to another record high price of $0.775 and with MAJOR contracts coming out of this weekend’s Medical Conference, expect EKNL to soar to more record highs.
EKNL is now at the 2012 CFPM 13th Annual Conference and we are getting initial word that key participants are very interested in EKNL and it’s FREMS technology.
The company announced already they are looking to finalized several deals, and we will be front and center when EKNL unleashes contract after contract.
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
$EKNL on high alert for next week!
$EKNL – On HIGH News alert for HUGE contract update from this weekend’s Conference
EKNL jumped to another record high price of $0.775 and with MAJOR contracts coming out of this weekend’s Medical Conference, expect EKNL to soar to more record highs.
EKNL is now at the 2012 CFPM 13th Annual Conference and we are getting initial word that key participants are very interested in EKNL and it’s FREMS technology.
The company announced already they are looking to finalized several deals, and we will be front and center when EKNL unleashes contract after contract.
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
$EKNL So much awareness around this play.. All eyes ready for the results from the Medical convention.. EKNL Huge $$$$$ gainer!
$EKNL Is the "Real Deal"
EKNL is building a monster inter-relationship of key medical clinics, doctors, and large medical companies.
The exposure will be HUGE with this weekend’s conference for EKNL and their FDA approved FREMS technologies. EKNL will also be increasing their exposure with 2 additional shows this year – a big step forward for the company and shareholder’s value.
EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario PR Newswire(Tue 10:04AM EDT)
EKNL continues to impress, and with the PR campaign gearing up, we anticipate a series of big updates and significant sales contract to follow as early as next week.
$EKNL All the fun starts next week.. Hope all that wanted in were able to climb on board!! $EKNL = $$$$
$EKNL Once the medical conference concludes Saturday and the updates start rolling in we'll all see the strength of EKNL. Smart investors will take this time to load and hold before the frenzy of buys come in.. $EKNL = $$$
$EKNL slowly churning and getting tighter ready for the "BOOM" Higher highs on the way!!
$EKNL is now at the 2012 CFPM 13th Annual Conference and it looks like some key participants are very interested in EKNL and it’s FREMS technology! No doubt they are seeing the same thing we are and trading at super cheap prices!
Dr. Paul Ziemer is now meeting with countless KEY medical companies and professionals today and tomorrow to finalize contracts that will no doubt be unleashed next week.
With exposure like this, EKNL is primed for the biggest breakout yet to push over the $2.00 price level on the backs of expected MONSTER contracts - this will definitely set the stage for a wild and crazy next week.
$EKNL – MONSTER BREAKOUT ALERT to record highs, HUGE contracts expected next week!
We are alert members to get what you can of EKNL before this weekend, it’s on a major tear this morning soaring 14.3% to record highs of $0.775 and is making a MAJOR breakout run.
EKNL is now at the 2012 CFPM 13th Annual Conference and it looks like some key participants are very interested in EKNL and it’s FREMS technology! No doubt they are seeing the same thing we are and trading at super cheap prices!
Dr. Paul Ziemer is now meeting with countless KEY medical companies and professionals today and tomorrow to finalize contracts that will no doubt be unleashed next week.
With exposure like this, EKNL is primed for the biggest breakout yet to push over the $2.00 price level on the backs of expected MONSTER contracts - this will definitely set the stage for a wild and crazy next week.
Dr. Paul Ziemer of NCI and J.V partner with EKNL will working very close with Dr. Kenneth J. Snow of Neurometrix a Nasdaq public company (NURO) at the conference.
This world renowned Medical show will give EKNL monster exposure with several key players working close with EKNL and their distribution of FREMS technology You can visit the events page here
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
Totally agree with you here.. MM's last ditch effort to hols us at this level..
$EKNL is the "REAL DEAL"
$EKNL We feast on shorties!! No stopping EKNL "STRONG"
EKNL – Expect some MAJOR contract from this weekend’s Medical conference to take this to $2.00!
The show starts tomorrow and Saturday, expect some HUGE contracts to come out of this show and HUGE press releases to take us to $2.00+ level.
EKNL will be attending the 13th annual Medical Show in London – this is HUGE! Dr. Paul Ziemer of NCI and J.V partner with EKNL will working very close with Dr. Kenneth J. Snow of Neurometrix a Nasdaq public company (NURO) at the conference.
This world renowned Medical show will give EKNL monster exposure with several key players working close with EKNL and their distribution of FREMS technology You can visit the events page here
Dr. Ziemer with Dr. Kenneth J. Snow will lead participants through hands on training sessions for the NC-stat DPN Check device, trademark and technology owner, Neurometrix. Definitely impressive and you have EKNL working closely with a large cap Nasdaq board company (NURO) and top professionals in the industry, rarely heard of for and OTC company this early on in their business development.
This alone sling shots EKNL right in deep with the big players!
$EKNL getting hits .73's up!
$EKNL getting hits .73's up!
$EKNL nice move upward this morning look for this to continue!!
All eyes on $EKNL also Medical conference starts today thru Saturday expecting a huge move on this! $$$$$
$EKNL This is going to be so "HUGE"
$EKNL is building a monster inter-relationship of key medical clinics, doctors, and large medical companies.
The exposure will be HUGE with this weekend’s conference for $EKNL and their FDA approved FREMS technologies. EKNL will also be increasing their exposure with 2 additional shows this year – a big step forward for the company and shareholder’s value.
EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario PR Newswire(Tue 10:04AM EDT)
EKNL continues to impress, and with the PR campaign gearing up, we anticipate a series of big updates and significant sales contract to follow as early as next week.
$EKNL is building a monster inter-relationship of key medical clinics, doctors, and large medical companies.
The exposure will be HUGE with this weekend’s conference for $EKNL and their FDA approved FREMS technologies. EKNL will also be increasing their exposure with 2 additional shows this year – a big step forward for the company and shareholder’s value.
EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario PR Newswire(Tue 10:04AM EDT)
EKNL continues to impress, and with the PR campaign gearing up, we anticipate a series of big updates and significant sales contract to follow as early as next week.
Starting today through Saturday
$EKNL will be attending the 13th annual Medical Show in London – this is HUGE! Dr. Paul Ziemer of NCI and J.V partner with EKNL will working very close with Dr. Kenneth J. Snow of Neurometrix a Nasdaq public company (NURO) at the conference.